Search Results 1561-1570 of 18300 for Topical

1. A Study to Evaluate PDS0101 and Pembrolizumab Combination to Treat Subjects with HPV16 + Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   or recent use of physiologic doses of intra-articular, topical, or inhaled corticosteroids is acceptable. - Has a known additional malignancy that is ...

2. Pembrolizumab With Chemotherapy and With/Without MK-4830 for Treating Participants With Ovarian Cancer - Mayo Clinic

   Note: Participants that require intermittent use of non-systemic steroids such as ocular, inhaled, intranasal, topical steroids, or local steroid injections are ...

3. Publications - Aziza Nassar, M.D., M.P.H. - Mayo Clinic

   ... Topical Anesthetic. Endocr Pract. 2020 Dec; 26 (12):1497-1504. View PubMed; McCann MR, Schenk WB, Nassar A, Maimone S. Thoracic endometriosis presenting as a ...

4. Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy in the Lung - Mayo Clinic

   After topical anaesthesia, the 1.4-mm miniprobe was introduced into the bronchoscope working channel and advanced distally to the alveoli. Morphometric and ...

5. A Study of 9-ING-41 in Patients with Advanced Cancers - Mayo Clinic

   - Systemic and topical corticosteroids - 7 days - Surgery with general anesthesia - 7 days - Surgery with local anesthesia - 3 days 8. May continue ...

6. Niraparib + TSR042 In BRCA Mutated Breast Cancer - Mayo Clinic

   injections), inhaled, intranasal, ophthalmic, and topical corticosteroids, and subjects requiring corticosteroid pre-medication for hypersensitivity ...

7. Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) - Mayo Clinic

   ... topical, ocular, intra-articular, intranasal and inhaled) - Systemic corticosteroids at physiologic doses ≤ 10 mg/day of prednisone or equivalent permitted

8. Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers - Mayo Clinic

   Steroids with no or minimal systemic effect (topical, inhalation) are allowed. Patients with central nervous system (CNS) metastases except those meeting ...

9. A study assessing esophageal function and remodeling with dupilumab compared with placebo for 24 weeks followed by 104 weeks open-label in adult participants with EoE - Mayo Clinic

   Treatment with swallowed topical corticosteroids within 8 weeks prior to baseline. Initiation, discontinuation, or change in the dosage regimen of the ...

10. Publications - Timothy D. Lyon, M.D. - Mayo Clinic

    Complete pathologic response of bulbar urethral squamous cell carcinoma in situ to topical 5-fluorouracil with urethral milking. Can J Urol. 2022 Apr; 29(2): ...